(Date:11/24/2009)...employment grew by 29,000 jobs in October, and th...owth during the U.S. recession. However, clinics a...th systems are coming closer to having to actually...tors. , (Vocus) November ...ng in October despite the shedding of jobs in most...
(Date:11/24/2009)...re-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abiop...alizingnovelpainmanagementtherapies,announcedtoday...er,isscheduledtopresentatthe21stAnnualPiperJaffray...NewYorkPalaceHotelinNewYork,NewYork. ,, Mr.DiTo...eavailabletorespondtoquestionsduringthepresentatio...
(Date:11/24/2009)...tly approved the Promega PowerPlex 16 HS System fo...ng DNA records for the National DNA Index System. ... -- The FBI recently approved the Promega PowerPl...icipating in, or generating DNA records for, the N...ntains more than seven million profiles and has as...
(Date:11/24/2009)...rstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglo...edthatithassubmittedaMAAtotheEuropeanMedicinesAgen...enttherapyindevelopment,forthetreatmentofType1Gauc...elaglucerasealfathathasbeensubmitted,withprevious,...donaglobalsupplyshortageofthecurrentlyapprovedandm...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3...ts for the Product,TopoTarget Successfully Buys Ba... the Global Rights for the Product ... Corporation, COPENHAGEN, April 22 , - Deal Cove..., a Total,of 5 Million TopoTarget Shares and a Com...all to be Held 2pm CET, TopoTarget A/S (OMX: TOPO...
...Ortho Evra is an adhesive,transdermal birth contro...lgestromin and 20 mcg of ethinyl estradiol into th...week for three weeks, and no patch is worn,during ...A in November,2001, and over 4 million women have ...tinues to be marketed aggressively to both consume...
.../PRNewswire-FirstCall/-- Pharmacyclics,Inc. (Nasda...aq staff,deficiency letter on April 17, 2008 indic...bid price for Pharmacyclics, common stock has clos...1.00 per share for continued,inclusion on The Nasd.... In,accordance with Marketplace Rule 4450(e)(2), ...
Other Biology Technology:TopoTarget Successfully Buys Back Full Control of Belinostat 2TopoTarget Successfully Buys Back Full Control of Belinostat 3TopoTarget Successfully Buys Back Full Control of Belinostat 4TopoTarget Successfully Buys Back Full Control of Belinostat 5TopoTarget Successfully Buys Back Full Control of Belinostat 6TopoTarget Successfully Buys Back Full Control of Belinostat 7Ortho Evra Patch Makers Settling Cases 2Anti-Taste Receptor 2 (TR2) Polyclonal Antibody, Unconjugated from CHEMICON
Anti-Latanoprost (EIA Antiserum) Antibody, Unconjugated from Cayman Chemical
Anti-SEK1 / MKK4, phospho (Thr261) Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-BACE/Asp2 (CT) Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents
Biology Products: